Cargando…

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases

Detalles Bibliográficos
Autores principales: Connolly, Caoilfhionn M, Chiang, Teresa Po-Yu, Teles, Mayan, Frey, Sarah, Alejo, Jennifer L, Massie, Allan, Shah, Ami A, Albayda, Jemima, Christopher-Stine, Lisa, Werbel, William A, Segev, Dorry L, Paik, Julie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963771/
https://www.ncbi.nlm.nih.gov/pubmed/35368386
http://dx.doi.org/10.1016/S2665-9913(22)00065-0
_version_ 1784678061503938560
author Connolly, Caoilfhionn M
Chiang, Teresa Po-Yu
Teles, Mayan
Frey, Sarah
Alejo, Jennifer L
Massie, Allan
Shah, Ami A
Albayda, Jemima
Christopher-Stine, Lisa
Werbel, William A
Segev, Dorry L
Paik, Julie J
author_facet Connolly, Caoilfhionn M
Chiang, Teresa Po-Yu
Teles, Mayan
Frey, Sarah
Alejo, Jennifer L
Massie, Allan
Shah, Ami A
Albayda, Jemima
Christopher-Stine, Lisa
Werbel, William A
Segev, Dorry L
Paik, Julie J
author_sort Connolly, Caoilfhionn M
collection PubMed
description
format Online
Article
Text
id pubmed-8963771
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89637712022-03-30 Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases Connolly, Caoilfhionn M Chiang, Teresa Po-Yu Teles, Mayan Frey, Sarah Alejo, Jennifer L Massie, Allan Shah, Ami A Albayda, Jemima Christopher-Stine, Lisa Werbel, William A Segev, Dorry L Paik, Julie J Lancet Rheumatol Comment Elsevier Ltd. 2022-06 2022-03-29 /pmc/articles/PMC8963771/ /pubmed/35368386 http://dx.doi.org/10.1016/S2665-9913(22)00065-0 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Connolly, Caoilfhionn M
Chiang, Teresa Po-Yu
Teles, Mayan
Frey, Sarah
Alejo, Jennifer L
Massie, Allan
Shah, Ami A
Albayda, Jemima
Christopher-Stine, Lisa
Werbel, William A
Segev, Dorry L
Paik, Julie J
Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
title Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
title_full Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
title_fullStr Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
title_full_unstemmed Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
title_short Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
title_sort factors associated with poor antibody response to third-dose sars-cov-2 vaccination in patients with rheumatic and musculoskeletal diseases
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963771/
https://www.ncbi.nlm.nih.gov/pubmed/35368386
http://dx.doi.org/10.1016/S2665-9913(22)00065-0
work_keys_str_mv AT connollycaoilfhionnm factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT chiangteresapoyu factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT telesmayan factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT freysarah factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT alejojenniferl factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT massieallan factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT shahamia factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT albaydajemima factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT christopherstinelisa factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT werbelwilliama factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT segevdorryl factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases
AT paikjuliej factorsassociatedwithpoorantibodyresponsetothirddosesarscov2vaccinationinpatientswithrheumaticandmusculoskeletaldiseases